Press Releases May 19, 2026 04:05 PM

iRhythm Holdings to Participate in Upcoming Investor Conferences

iRhythm Holdings Announces Participation in Upcoming Mid-2026 Investor Conferences

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
IRTC

iRhythm Holdings, a NASDAQ-listed digital healthcare company specialized in wearable biosensors and data analytics for disease detection and prediction, announced its participation in two key investor conferences in June 2026, including the William Blair 46th Annual Growth Stock Conference and the Truist Securities MedTech Conference. The company will provide live and archived webcasts for investors.

iRhythm Holdings to Participate in Upcoming Investor Conferences
IRTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • iRhythm Holdings is scheduled to present at two major investor conferences in June 2026, showcasing its business and technology.
  • The company specializes in digital healthcare solutions that use wearable biosensors combined with cloud analytics and proprietary algorithms to monitor heart health.
  • Investor access to live and archived presentations facilitates transparency and engagement with stakeholders.

SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that the company will be participating in the following investor conferences.

William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 8:00 a.m. CT (6:00 a.m. PT)
Truist Securities MedTech Conference on June 16, 2026, at 2:20 p.m. ET (11:20 a.m. PT)

Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
investors@irhythmtech.com

Media Contact
Kassandra Perry
mediarelations@irhythmtech.com


Risks

  • Market reception to the company’s presentations is uncertain and may not lead to increased investor interest or stock appreciation.
  • Advancements and adoption of wearable healthcare technology face competitive pressure and regulatory scrutiny in the MedTech sector.
  • Broader healthcare market volatility and macroeconomic conditions could impact investor confidence despite the company’s outreach efforts.

More from Press Releases

Diana Shipping Inc. Alerts Genco Shareholders of Institutional Shareholder Services’ Recommendation to Vote Against Genco Shipping & Trading's Poison Pill Jun 9, 2026 Mingteng International Corporation Inc. Announces Pricing of $2.26 Million Registered Direct Offering Jun 9, 2026 Toll Brothers Announces Model Home Grand Opening at Santa Rita Ranch in Liberty Hill, Texas Jun 9, 2026 Toll Brothers Announces Final Opportunity to Own a New Luxury Home at Toll Brothers at Skye Canyon - Paloma Collection in Las Vegas, Nevada Jun 9, 2026 CORRECTION Jun 9, 2026